Model & sampleNormal lung and human kidney organoids, with kidney model source and culture approach selected for each study
Study setupLPS lung-injury conditions and kidney drug-injury studies inform organ-specific exposure and control design for a new candidate
AssaysLung: serial morphology, AT1/AT2, ATII-associated LysoTracker signal, SCGB1A1 (CC10) and KRT5; kidney: Nephrin/LTL-associated identity profiling and a doxorubicin injury time course
STUDY EVIDENCE
Lung and kidney organoids for safety studies
Separate lung and kidney studies show organ identity and injury responses.
Normal lung: identity and LPS injury4 study figures
Morphology before and 24/48 hours after doxorubicin exposure
Bright-field images before and 24 and 48 hours after doxorubicin exposure show changes in kidney organoid morphology.
View study figure set+
↗Normal lung and kidney organoid safety-study figure set
Alveolar and airway markers, kidney organoid morphology and nephron-associated staining show the model features of both organs.
Study application
Separate lung and kidney studies show organ-specific identity and injury endpoints that can guide complementary safety evaluations for the same candidate.